Company intelligence / Profile preview
Threebrooks Therapeutics
Cambridge, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Threebrooks Therapeutics is a preclinical-stage biotechnology company focused on developing novel small molecule therapeutics for the treatment of cancer. The company's primary research centers on modulating the Integrated Stress Response (ISR) pathway, specifically targeting GCN2 to overcome immune suppression within the tumor microenvironment. By inhibiting GCN2, Threebrooks aims to restore anti-tumor immune activity and enhance the efficacy of existing immunotherapies. The company is currently advancing its lead programs toward IND-enabling studies. Headquartered in Cambridge, Massachusetts, the firm leverages deep expertise in kinase biology to address significant unmet needs in oncology.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Threebrooks Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Threebrooks Therapeutics.